1.23 (2.91%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Weak
Garp
Strong
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Weak
Earnings
Strong
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Very Weak
Website
Travere Therapeutics, Inc.
Telephone
1.888.969.7879
Address
Suite 300, 3611 Valley Centre Drive, San Diego, CA 92130
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 13.88 - 48.61
Trade Value (12mth)
US$14,425,472.00
1 week
-0.77%
1 month
8.97%
YTD
6.93%
1 year
154.58%
All time high
765.00
EPS 3 yr Growth
-87.10%
EBITDA Margin
-0.40%
Operating Cashflow
$38m
Free Cash Flow Return
9.20%
ROIC
-12.20%
Interest Coverage
-0.20
Quick Ratio
2.70
Shares Outstanding (Fully Diluted)
92m
HALO Sector
Healthcare
Next Company Report Date
25-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 12 May 26 | |
| 08 May 26 | |
| 08 May 26 | |
| 06 May 26 | |
| 05 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -4.54 | -4.08 | -0.56 | | | | ||
EPS (Fully Diluted) | $ | | | | | -4.54 | -4.08 | -0.56 | | | | ||
Growth | % | | | | | -4 | 10.3 | 86.2 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
